Stockreport

J&J wins FDA nod for plaque psoriasis pill developed with Protagonist [Seeking Alpha]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF Food and Drug Administration (FDA) approved Icotyde, a once-daily pill developed with Protagonist Therapeutics ( PTGX ), as a treatment for plaque psoriasis, a skin-rela [Read more]